In the case of a 38-year-old female with a completely resected IDH-mutant grade 2 astrocytoma, the majority of clinicians (93%) recommended observation alone as the preferred management strategy [Figure 2]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).